Results of 280 Liver Resections for Hepatocellular Carcinoma

Takenaka, Katsuto; Kawahara, Nobuaki; Yamamoto, Ken; Kawakami, Kiyoshi; Maeda, Takashi; Itasaka, Hidetoshi; Shirabe, Ken; Nishizaki, Takashi; Yanaga, Katsuhiko; Sugimachi, Keizō

doi:10.1001/archsurg.1996.01430130073014

Cited by 207 publications

(133 citation statements)

References 26 publications

Supporting

Mentioning

125

Contrasting

Unclassified

Order By: Relevance

“…the cumulative probability of avoiding both death and disease recurrence) predominantly fall within the following ranges: 50-80% at 1 year, 30-50% at 3 years, 15-40% at 5 years and 8-20% at 10 years. 158,166,173,174,[176][177][178][179][180][181][182][183][184][185][186][187][188][189][190][191][192][193] …”

Section: Disease Recurrencementioning

confidence: 99%

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

Coon¹,

Rogers²,

Hewson³

et al. 2007

Health Technol Assess

152

108

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. Declared competing interests of authors: K Stein received an unrestricted grant from Schering Plough (UK) to carry out work on the cost-effectiveness of combination therapy for hepatitis C in 2000. KS is also a member of the editorial board for Health Technology Assessment, but he was not involved in the editorial process for this report. M Cramp sits on hepatitis C advisory boards for Schering Plough, Gilead and Roche. He has received unrestricted educational grants from Roche and Schering Plough to support research and service development. He has been awarded an NHS R&D grant looking at injecting drug users who do not have hepatitis C virus infection. J Thompson Coon received a grant from the Hepatitis C Trust to conduct a systematic review of complementary and alternative therapies for the treatment of chronic hepatitis C. HTA Published September 2007This report should be referenced as follows: NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, man...

show abstract

Section: Disease Recurrencementioning

confidence: 99%

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

Coon¹,

Rogers²,

Hewson³

et al. 2007

Health Technol Assess

152

108

View full text Add to dashboard Cite

show abstract

“…Hepatocellular carcinoma (HCC) accounts for more than 90% of all primary liver cancers and represents approximately 40% of all cancers in South-East Asia, Japan and Africa (Akriviadis et al, 1998). The majority of these HCC cases is often inoperable (Okuda et al, 1985) and the 5-year survival rate is limited to 25-50% after surgery (Colombo, 1992;Lai et al, 1995;Takenaka et al, 1996). Long-term survival is uncommon owing to frequent recurrence, metastasis or the development of new primaries (Lai, 1994;Huguet, 2000) and the current adjuvant or palliative treatment modalities are not able to conclusively prolong survival of patients with HCC (Chan et al, 2000).…”

Section: Introductionmentioning

confidence: 99%

The role of 5′ untranslated region in translational suppression of OKL38 mRNA in hepatocellular carcinoma

et al. 2006

View full text Add to dashboard Cite

show abstract

“…The recurrent peak is found at six months or 1 year after operation and most of the early postoperative recurrence is intrahepatic metastasis [18] , which is attributed to the characteristics of vascular invasion propensity of HCCs. The appearance of tiny tumors through venous invasion in the liver is the main sign for potential HCC recurrence after surgery [19][20][21][22][23][24][25][26][27][28][29] . The intrahepatic metastasis of the tumor cells through the portal venous system is believed to be an important mechanism for HCC recurrence [24,30,31] .…”

Section: Discussionmentioning

confidence: 99%

Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy

Wang¹,

Yin²,

Yu³

et al. 2008

WJG

View full text Add to dashboard Cite

show abstract

Results of 280 Liver Resections for Hepatocellular Carcinoma

Abstract: The recent results of liver resection for hepatocellular carcinoma are generally satisfactory; however, the recurrence rate is still high.

Cited by 207 publications

References 26 publications

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

The role of 5′ untranslated region in translational suppression of OKL38 mRNA in hepatocellular carcinoma

Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy

Contact Info

Product

Resources

About